Sulindac Enhances the Killing of Cancer Cells Exposed to Oxidative Stress

BACKGROUND: Sulindac is an FDA-approved non-steroidal anti-inflammatory drug (NSAID) that affects prostaglandin production by inhibiting cyclooxygenases (COX) 1 and 2. Sulindac has also been of interest for more than decade as a chemopreventive for adenomatous colorectal polyps and colon cancer. PRI...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Marchetti, Maria, Resnick, Lionel, Gamliel, Edna, Kesaraju, Shailaja, Weissbach, Herbert, Binninger, David
Format: Artigo
Langue:Inglês
Publié: Public Library of Science 2009
Sujets:
Research Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC2686156/
https://ncbi.nlm.nih.gov/pubmed/19503837
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0005804
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires